543520 — Global Longlife Hospital and Research Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹298.62m
- IN₹83.70m
- IN₹5.77m
- 43
- 26
- 27
- 20
Annual cashflow statement for Global Longlife Hospital and Research, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 18.2 | 57.1 | 27.1 | -22.7 | 0.992 |
| Depreciation | |||||
| Non-Cash Items | -0.828 | 27 | 7.04 | -348 | -33.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 59.2 | -1.25 | -450 | 308 | 151 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 95.3 | 94.2 | -404 | -50.7 | 123 |
| Capital Expenditures | -0.423 | -4.75 | -20.2 | -10.5 | -0.724 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.598 | 4.89 | 1.22 | 2.31 | 219 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.175 | 0.132 | -19 | -8.18 | 218 |
| Financing Cash Flow Items | -24.3 | -13.1 | -4 | -7.68 | -2.76 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -100 | -96.6 | 457 | 26.7 | -130 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -4.77 | -2.22 | 33.8 | -32.2 | 211 |